Ziconotide Acetate Patent Expiration
Ziconotide Acetate is Used for managing severe chronic pain through intrathecal infusion in patients also receiving morphine. It was first introduced by Tersera Therapeutics Llc
Ziconotide Acetate Patents
Given below is the list of patents protecting Ziconotide Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prialt | US8653033 | Method for administering omega-conopeptide |
Oct 01, 2024
(Expired) | Tersera |
| Prialt | US8765680 | Method for administering omega-conopeptide |
Oct 01, 2024
(Expired) | Tersera |
| Prialt | US9707270 | Method for administering ω-conopeptide |
Oct 01, 2024
(Expired) | Tersera |
| Prialt | US5364842 | Method of producing analgesia |
Dec 30, 2016
(Expired) | Tersera |
| Prialt | US5795864 | Stable omega conopetide formulations |
Jun 27, 2015
(Expired) | Tersera |
Ziconotide Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List